NEAT1 Decreasing Suppresses Parkinson’s Disease Progression via Acting as miR-1301-3p Sponge
Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP + -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP + -induced neuronal apopto...
Saved in:
Published in | Journal of molecular neuroscience Vol. 71; no. 2; pp. 369 - 378 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.02.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0895-8696 1559-1166 1559-1166 |
DOI | 10.1007/s12031-020-01660-2 |
Cover
Loading…
Abstract | Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP
+
-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP
+
-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP
+
-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP
+
-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP
+
-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment. |
---|---|
AbstractList | Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP+-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP+-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP+-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP+-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP+-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment.Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP+-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP+-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP+-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP+-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP+-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment. Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP+-induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP+-induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP+-induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP+-induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP+-induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment. Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP -induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP -induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP -induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP -induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment. Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased lncRNA NEAT1 was discovered in MPP + -induced SH-SY5Y cells. Then, we proved that NEAT1 decreasing suppressed MPP + -induced neuronal apoptosis, upregulation of α-syn and activation of NLRP3 inflammasome. Rescue experiments shown that the inhibition of NEAT1 decreasing to MPP + -induced activation of NLRP3 inflammasome and subsequent neuronal apoptosis can be reversed by overexpressed α-syn. Subsequently, we indicated the interaction between NEAT1 and miR-1301-3p, as well as between NEAT1 and miR-5047. Interesting, we found that NEAT1 decreasing repressed the expression of GJB1, a downstream target of miR-1301-3p and miR-5047, through promoting miR-1301-3p rather than miR-5047 expression. Finally, we transfected miR-1301-3p inhibitor to MPP + -induced SH-SY5Y cells following si-NEAT1, and found that downregulation of NEAT1 repressed α-syn-mediated the activation of NLRP3 inflammasome through regulating miR-1301-3p/GJB1 signaling pathway. Overall, our data demonstrated that NEAT1 decreasing effectively suppressed MPP + -induced neuronal apoptosis. Mechanismly, downregulation of NEAT1 repressed α-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. Our study supported a new and reliable evidence for lncRNA NEAT1 as a potential target for PD treatment. |
Author | Xing, Yu Chen, Zengfeng Zhang, Yueliang Cai, Hongxia Chen, Jun Sun, Qiang Wang, Songlin Yang, Fang |
Author_xml | – sequence: 1 givenname: Qiang surname: Sun fullname: Sun, Qiang organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine – sequence: 2 givenname: Yueliang surname: Zhang fullname: Zhang, Yueliang organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine – sequence: 3 givenname: Songlin surname: Wang fullname: Wang, Songlin organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine – sequence: 4 givenname: Fang surname: Yang fullname: Yang, Fang organization: Department of Oncology, TaiHe Hospital, Hubei University of Medicine – sequence: 5 givenname: Hongxia surname: Cai fullname: Cai, Hongxia organization: Department of Obstetrics and Gynecology, TaiHe Hospital, Hubei University of Medicine – sequence: 6 givenname: Yu surname: Xing fullname: Xing, Yu organization: Department of Medical Image Center, TaiHe Hospital, Hubei University of Medicine – sequence: 7 givenname: Zengfeng surname: Chen fullname: Chen, Zengfeng organization: Chronic Disease Rehabilitation Centre 1, TaiHe Hospital, Hubei University of Medicine – sequence: 8 givenname: Jun orcidid: 0000-0002-8257-0837 surname: Chen fullname: Chen, Jun email: drcj2019@163.com organization: Department of Neurology, TaiHe Hospital, Hubei University of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32712773$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1uFDEQhC0URDaBF-CALHHhYui2Z8Yzx1USfqQIIhKuWN6xZ-Wwaw_uGSRueY28Hk-Cl02ElENOrZa-KpWqjthBTNEz9hLhLQLod4QSFAqQIACbBoR8whZY153A8h6wBbRdLdqmaw7ZEdE1gMQK22fsUEmNUmu1YN8_ny2vkJ_6PntLIa755TyO2RN54hc2_wiRUvxzc0v8NFBBPL_Iab0DQor8V7B82U87nSW-DV8FKkChRn45prj2z9nTwW7Iv7i7x-zb-7Ork4_i_MuHTyfLc9ErXU-is2jdsJKqaxvXO4mrTrtm8LJuwHV-0M7VCl2B-lW5rh4sVq2GQXlVOZDqmL3Z-445_Zw9TWYbqPebjY0-zWRkJXUtVVtBQV8_QK_TnGNJVyjdKC1LjEK9uqPm1dY7M-awtfm3uW-uAO0e6HMiyn4wfZjsVEqZsg0bg2B2I5n9SKaMZP6NZHZh5QPpvfujIrUXUYFLs_l_7EdUfwHpR6KS |
CitedBy_id | crossref_primary_10_1016_j_bbadis_2024_167454 crossref_primary_10_3390_ijms21249500 crossref_primary_10_2174_1381612828666220922110551 crossref_primary_10_1002_iid3_817 crossref_primary_10_1007_s12264_023_01023_y crossref_primary_10_3390_ijms25116146 crossref_primary_10_1186_s13018_023_04511_z crossref_primary_10_1016_j_exger_2024_112436 crossref_primary_10_3389_fncel_2023_1044634 crossref_primary_10_1016_j_wneu_2021_08_147 crossref_primary_10_3390_ijms22189839 crossref_primary_10_1007_s00702_022_02479_4 crossref_primary_10_3390_antiox13050606 crossref_primary_10_3389_fnmol_2021_685143 crossref_primary_10_2174_1874609815666220126095847 crossref_primary_10_4103_1673_5374_358615 crossref_primary_10_1080_21655979_2022_2062989 crossref_primary_10_1007_s12035_023_03809_7 crossref_primary_10_1007_s12035_023_03849_z crossref_primary_10_1016_j_arr_2023_101878 crossref_primary_10_18632_aging_206028 crossref_primary_10_1093_nar_gkaf074 crossref_primary_10_2147_DMSO_S355783 crossref_primary_10_3389_fnagi_2021_650840 crossref_primary_10_3390_brainsci13010150 crossref_primary_10_3390_ph15070811 crossref_primary_10_2147_JIR_S338162 crossref_primary_10_3233_JPD_202374 |
Cites_doi | 10.1002/1878-0261.12404 10.1016/j.brainres.2020.146672 10.1093/nar/gkz621 10.1016/j.neulet.2019.134340 10.1261/rna.071456.119 10.1177/1073858417748875 10.1007/s00415-016-8213-1 10.1111/acel.13115 10.1002/mds.27874 10.1016/j.bbrc.2017.12.149 10.1016/j.yexcr.2019.111614 10.1001/jamaneurol.2017.3517 10.1042/BJ20150617 10.1007/s00018-019-03074-9 10.1001/jamaneurol.2018.1487 10.1002/mds.27602 10.1016/j.ejphar.2020.173056 10.1126/scitranslmed.aah4066 10.1096/fj.201900830R 10.1007/s00401-019-02007-x 10.1186/s13024-016-0094-3 10.1080/21691401.2019.1636805 10.1016/j.cbi.2019.04.017 10.1007/s00018-020-03503-0 10.1111/cpr.12329 10.1007/s10620-019-06020-8 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2020 Springer Science+Business Media, LLC, part of Springer Nature 2020. |
Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2020 – notice: Springer Science+Business Media, LLC, part of Springer Nature 2020. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QR 7T7 7TK 7U9 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 K9. M0S M1P M2M M7N P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1007/s12031-020-01660-2 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Psychology MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1559-1166 |
EndPage | 378 |
ExternalDocumentID | 32712773 10_1007_s12031_020_01660_2 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Science and Technology Research Development plan project of Shaanxi Province grantid: No.2010R034-2 |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VX 0VY 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 3V. 4.4 406 408 40D 40E 44B 53G 5GY 5RE 5VS 67N 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 H13 HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M1P M2M M4Y MA- MVM N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR Z7U Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QL 7QR 7T7 7TK 7U9 7XB 8FD 8FK ABRTQ C1K FR3 H94 K9. M7N P64 PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c375t-9a1adfb23986dcd21b97d6fe2560d9ef7dd531d1adcb31dd5fa14870f3e34d023 |
IEDL.DBID | U2A |
ISSN | 0895-8696 1559-1166 |
IngestDate | Mon Jul 21 10:47:35 EDT 2025 Fri Jul 25 23:50:20 EDT 2025 Thu Apr 03 07:05:44 EDT 2025 Thu Apr 24 23:05:30 EDT 2025 Tue Jul 01 03:06:28 EDT 2025 Fri Feb 21 02:33:52 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Parkinson disease Nuclear enriched assembly transcript 1 Neuronal apoptosis NLRP3 inflammasome Endogenous competing RNA |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-9a1adfb23986dcd21b97d6fe2560d9ef7dd531d1adcb31dd5fa14870f3e34d023 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-8257-0837 |
PMID | 32712773 |
PQID | 2476372239 |
PQPubID | 326248 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2427523840 proquest_journals_2476372239 pubmed_primary_32712773 crossref_citationtrail_10_1007_s12031_020_01660_2 crossref_primary_10_1007_s12031_020_01660_2 springer_journals_10_1007_s12031_020_01660_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210200 2021-02-00 2021-Feb 20210201 |
PublicationDateYYYYMMDD | 2021-02-01 |
PublicationDate_xml | – month: 2 year: 2021 text: 20210200 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Totowa |
PublicationSubtitle | MN |
PublicationTitle | Journal of molecular neuroscience |
PublicationTitleAbbrev | J Mol Neurosci |
PublicationTitleAlternate | J Mol Neurosci |
PublicationYear | 2021 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Balestrino, Schapira (CR2) 2018; 24 Haque, Akther, Jakaria, Kim, Azam, Choi (CR7) 2020; 35 Wu, Yao, Chen, Chen, Huang, Liu, Cai, Yuan, Hei (CR21) 2020; 876 Yan, Chen, Chen, Chen (CR25) 2018; 496 Wang, Zhao, Xu, Zhang, Wang, Mao, Zhu, Li, Jiang, Tan, Xie, Yang, Zhang (CR19) 2019; 76 Klec, Prinz, Pichler (CR10) 2019; 13 Seppi, Ray Chaudhuri (CR16) 2019; 34 Adriaens, Rambow (CR1) 2019; 25 Jankovic, Goodman, Safirstein, Marmon, Schenk, Koller, Zago, Ness, Griffith, Grundman, Soto, Ostrowitzki, Boess, Martin-Facklam, Quinn, Isaacson, Omidvar, Ellenbogen, Kinney (CR8) 2018; 75 Xiong, Sun, Guan, Luo, Chen, An, Wang, Wu (CR23) 2016; 263 Ding, Zhao, Qiao, Wu, Wang (CR4) 2019; 307 Peng, Liu, Wang, Liu, Fu, Ma, Li, Sun, Ji, Lu, Wan, Lu (CR12) 2019; 47 Xie, Zhou, Li, Duan (CR22) 2019; 708 Schenkman, Moore, Kohrt, Hall, Delitto, Comella, Josbeno, Christiansen, Berman, Kluger, Melanson, Jain, Robichaud, Poon, Corcos (CR15) 2018; 75 Reyes, Sackmann, Hoffmann, Svenningsson, Winkler, Ingelsson, Hallbeck (CR14) 2019; 138 Gustot, Gallea, Sarroukh, Celej, Ruysschaert, Raussens (CR6) 2015; 471 Boros, Maszlag-Török, Vécsei, Klivényi (CR3) 2020; 1730 Jiang, Cheng, Ren, Wang, Kang, Ding, Hou, Yang, Lin, Liang, Gao (CR9) 2019; 47 Nussbaum (CR11) 2017; 7 Qian, Ye, Mao, Yao, Sun, Wang, Zhang, Xie, Zhang, Zhang, Zhang, He (CR13) 2019; 384 Simchovitz, Hanan, Niederhoffer, Madrer, Yayon, Bennett, Greenberg, Kadener, Soreq (CR17) 2019; 33 CR27 CR26 Zhou, Lu, Du, Qiao, Jiang, Zhang, Ding, Hu (CR28) 2016; 11 CR20 Simchovitz, Hanan, Yayon, Lee, Bennett, Greenberg, Kadener, Soreq (CR18) 2020; 19 Gordon, Albornoz (CR5) 2018; 10 Xu, Zhuang, Wu, Qiu, Feng, Wu (CR24) 2018; 2018 R Balestrino (1660_CR2) 2018; 24 XM Ding (1660_CR4) 2019; 307 ME Haque (1660_CR7) 2020; 35 Y Zhou (1660_CR28) 2016; 11 C Qian (1660_CR13) 2019; 384 RL Nussbaum (1660_CR11) 2017; 7 C Adriaens (1660_CR1) 2019; 25 R Gordon (1660_CR5) 2018; 10 SP Xie (1660_CR22) 2019; 708 1660_CR20 X Xu (1660_CR24) 2018; 2018 M Schenkman (1660_CR15) 2018; 75 T Peng (1660_CR12) 2019; 47 J Jankovic (1660_CR8) 2018; 75 A Simchovitz (1660_CR18) 2020; 19 FA Boros (1660_CR3) 2020; 1730 K Seppi (1660_CR16) 2019; 34 Z Wang (1660_CR19) 2019; 76 1660_CR27 C Klec (1660_CR10) 2019; 13 S Wu (1660_CR21) 2020; 876 A Simchovitz (1660_CR17) 2019; 33 WX Xiong (1660_CR23) 2016; 263 A Gustot (1660_CR6) 2015; 471 S Jiang (1660_CR9) 2019; 47 JF Reyes (1660_CR14) 2019; 138 W Yan (1660_CR25) 2018; 496 1660_CR26 |
References_xml | – volume: 13 start-page: 46 issue: 1 year: 2019 end-page: 60 ident: CR10 article-title: Involvement of the long noncoding RNA NEAT1 in carcinogenesis publication-title: Mol Oncol doi: 10.1002/1878-0261.12404 – volume: 1730 start-page: 146672 year: 2020 ident: CR3 article-title: Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson's disease publication-title: Brain Res doi: 10.1016/j.brainres.2020.146672 – volume: 47 start-page: 7842 issue: 15 year: 2019 end-page: 7856 ident: CR9 article-title: An expanded landscape of human long noncoding RNA publication-title: Nucleic Acids Res doi: 10.1093/nar/gkz621 – volume: 708 start-page: 134340 year: 2019 ident: CR22 article-title: NEAT1 regulates MPP(+)-induced neuronal injury by targeting miR-124 in neuroblastoma cells publication-title: Neurosci Lett doi: 10.1016/j.neulet.2019.134340 – volume: 25 start-page: 1681 issue: 12 year: 2019 end-page: 1695 ident: CR1 article-title: The long noncoding RNA NEAT1_1 is seemingly dispensable for normal tissue homeostasis and cancer cell growth publication-title: RNA doi: 10.1261/rna.071456.119 – volume: 24 start-page: 540 issue: 5 year: 2018 end-page: 559 ident: CR2 article-title: Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications publication-title: Neuroscientist doi: 10.1177/1073858417748875 – volume: 263 start-page: 1984 issue: 10 year: 2016 end-page: 1992 ident: CR23 article-title: The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review publication-title: J Neurol doi: 10.1007/s00415-016-8213-1 – volume: 19 issue: 3 year: 2020 ident: CR18 article-title: A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra publication-title: Aging Cell doi: 10.1111/acel.13115 – volume: 35 start-page: 20 issue: 1 year: 2020 end-page: 33 ident: CR7 article-title: Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease publication-title: Mov Disord doi: 10.1002/mds.27874 – volume: 496 start-page: 1019 issue: 4 year: 2018 end-page: 1024 ident: CR25 article-title: LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2017.12.149 – ident: CR27 – volume: 384 start-page: 111614 issue: 1 year: 2019 ident: CR13 article-title: Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221/222 /p27/mTOR pathway in Parkinson's disease publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2019.111614 – volume: 2018 start-page: 8181374 year: 2018 ident: CR24 article-title: LincRNA-p21 inhibits cell viability and promotes cell apoptosis in Parkinson's disease through activating α-Synuclein expression publication-title: Biomed Res Int – volume: 7 start-page: S43 issue: s1 year: 2017 end-page: s49 ident: CR11 article-title: The identification of alpha-Synuclein as the first Parkinson disease gene publication-title: J Park Dis – volume: 75 start-page: 219 issue: 2 year: 2018 end-page: 226 ident: CR15 article-title: Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2017.3517 – volume: 471 start-page: 323 issue: 3 year: 2015 end-page: 333 ident: CR6 article-title: Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease publication-title: Biochem J doi: 10.1042/BJ20150617 – volume: 76 start-page: 3005 issue: 15 year: 2019 end-page: 3018 ident: CR19 article-title: NEAT1 regulates neuroglial cell mediating Abeta clearance via the epigenetic regulation of endocytosis-related genes expression publication-title: Cell Mol Life Sci doi: 10.1007/s00018-019-03074-9 – volume: 75 start-page: 1206 issue: 10 year: 2018 end-page: 1214 ident: CR8 article-title: Safety and tolerability of multiple ascending doses of PRX002/RG7935, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson disease: a randomized clinical trial publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2018.1487 – volume: 34 start-page: 180 issue: 2 year: 2019 end-page: 198 ident: CR16 article-title: Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review publication-title: Mov Disord doi: 10.1002/mds.27602 – volume: 876 start-page: 173056 year: 2020 ident: CR21 article-title: Connexin 32 deficiency protects the liver against ischemia/reperfusion injury publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173056 – volume: 10 start-page: eaah4066 issue: 465 year: 2018 ident: CR5 article-title: Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aah4066 – volume: 33 start-page: 11223 issue: 10 year: 2019 end-page: 11234 ident: CR17 article-title: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress publication-title: FASEB J doi: 10.1096/fj.201900830R – volume: 138 start-page: 23 issue: 1 year: 2019 end-page: 47 ident: CR14 article-title: Binding of alpha-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes publication-title: Acta Neuropathol doi: 10.1007/s00401-019-02007-x – volume: 11 start-page: 28 year: 2016 ident: CR28 article-title: MicroRNA-7 targets nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease publication-title: Mol Neurodegener doi: 10.1186/s13024-016-0094-3 – volume: 47 start-page: 2764 issue: 1 year: 2019 end-page: 2774 ident: CR12 article-title: Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation publication-title: Artif Cells Nanomed Biotechnol doi: 10.1080/21691401.2019.1636805 – ident: CR26 – ident: CR20 – volume: 307 start-page: 73 year: 2019 end-page: 81 ident: CR4 article-title: Long non-coding RNA-p21 regulates MPP(+)-induced neuronal injury by targeting miR-625 and derepressing TRPM2 in SH-SY5Y cells publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2019.04.017 – volume: 47 start-page: 2764 issue: 1 year: 2019 ident: 1660_CR12 publication-title: Artif Cells Nanomed Biotechnol doi: 10.1080/21691401.2019.1636805 – volume: 76 start-page: 3005 issue: 15 year: 2019 ident: 1660_CR19 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-019-03074-9 – volume: 10 start-page: eaah4066 issue: 465 year: 2018 ident: 1660_CR5 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aah4066 – volume: 19 issue: 3 year: 2020 ident: 1660_CR18 publication-title: Aging Cell doi: 10.1111/acel.13115 – ident: 1660_CR20 doi: 10.1007/s00018-020-03503-0 – ident: 1660_CR26 doi: 10.1111/cpr.12329 – volume: 13 start-page: 46 issue: 1 year: 2019 ident: 1660_CR10 publication-title: Mol Oncol doi: 10.1002/1878-0261.12404 – volume: 75 start-page: 1206 issue: 10 year: 2018 ident: 1660_CR8 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2018.1487 – volume: 24 start-page: 540 issue: 5 year: 2018 ident: 1660_CR2 publication-title: Neuroscientist doi: 10.1177/1073858417748875 – volume: 7 start-page: S43 issue: s1 year: 2017 ident: 1660_CR11 publication-title: J Park Dis – volume: 11 start-page: 28 year: 2016 ident: 1660_CR28 publication-title: Mol Neurodegener doi: 10.1186/s13024-016-0094-3 – ident: 1660_CR27 doi: 10.1007/s10620-019-06020-8 – volume: 35 start-page: 20 issue: 1 year: 2020 ident: 1660_CR7 publication-title: Mov Disord doi: 10.1002/mds.27874 – volume: 384 start-page: 111614 issue: 1 year: 2019 ident: 1660_CR13 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2019.111614 – volume: 263 start-page: 1984 issue: 10 year: 2016 ident: 1660_CR23 publication-title: J Neurol doi: 10.1007/s00415-016-8213-1 – volume: 471 start-page: 323 issue: 3 year: 2015 ident: 1660_CR6 publication-title: Biochem J doi: 10.1042/BJ20150617 – volume: 75 start-page: 219 issue: 2 year: 2018 ident: 1660_CR15 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2017.3517 – volume: 876 start-page: 173056 year: 2020 ident: 1660_CR21 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173056 – volume: 2018 start-page: 8181374 year: 2018 ident: 1660_CR24 publication-title: Biomed Res Int – volume: 33 start-page: 11223 issue: 10 year: 2019 ident: 1660_CR17 publication-title: FASEB J doi: 10.1096/fj.201900830R – volume: 47 start-page: 7842 issue: 15 year: 2019 ident: 1660_CR9 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkz621 – volume: 1730 start-page: 146672 year: 2020 ident: 1660_CR3 publication-title: Brain Res doi: 10.1016/j.brainres.2020.146672 – volume: 496 start-page: 1019 issue: 4 year: 2018 ident: 1660_CR25 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2017.12.149 – volume: 25 start-page: 1681 issue: 12 year: 2019 ident: 1660_CR1 publication-title: RNA doi: 10.1261/rna.071456.119 – volume: 138 start-page: 23 issue: 1 year: 2019 ident: 1660_CR14 publication-title: Acta Neuropathol doi: 10.1007/s00401-019-02007-x – volume: 708 start-page: 134340 year: 2019 ident: 1660_CR22 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2019.134340 – volume: 307 start-page: 73 year: 2019 ident: 1660_CR4 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2019.04.017 – volume: 34 start-page: 180 issue: 2 year: 2019 ident: 1660_CR16 publication-title: Mov Disord doi: 10.1002/mds.27602 |
SSID | ssj0021418 |
Score | 2.4201827 |
Snippet | Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson’s disease (PD) is still unclear. Here, the increased... Long non-coding RNA (lncRNA) plays a crucial role in multiple disorders, while the role of it in Parkinson's disease (PD) is still unclear. Here, the increased... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 369 |
SubjectTerms | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology alpha-Synuclein - physiology Apoptosis Apoptosis - drug effects Apoptosis Regulatory Proteins - biosynthesis Apoptosis Regulatory Proteins - genetics Biomedical and Life Sciences Biomedicine Cell Biology Cell Line Connexins - biosynthesis Connexins - genetics Disease Progression Down-Regulation Gap Junction beta-1 Protein Gene Expression Regulation - drug effects Gene Knockdown Techniques Humans Inflammasomes Inflammasomes - physiology MicroRNAs - antagonists & inhibitors MicroRNAs - genetics Movement disorders MPP Neurochemistry Neurodegenerative diseases Neurology Neurons - drug effects Neurons - metabolism Neurosciences NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors NLR Family, Pyrin Domain-Containing 3 Protein - biosynthesis NLR Family, Pyrin Domain-Containing 3 Protein - genetics Non-coding RNA Parkinson Disease - genetics Parkinson's disease Proteomics RNA, Long Noncoding - biosynthesis RNA, Long Noncoding - genetics Signal Transduction |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NTtwwEB4VeuGCaCkQSitXQr2ARewkdnyqVgWEKhWhFqQ9ETm2IyFBdtsslbjxGn29PklnnOyuKlROOayzsWY8nv9vAPZ1USupm5xnMi3QQSktt40QPAS8JnPlShchNr6eq7Or_Mu4GA8Bt24oq5zfifGi9hNHMfIjmaMkaFRm5tP0B6epUZRdHUZorMBLgi6jki49XjpcIo_xvbQ0BS-VUUPTTN86J_E4c3Ke0OhRKZf_KqYn1uaTTGlUQKcbsD5YjmzUs_oVvAjta9gcteg13z2wjyzWcsYg-SZcn5-MLgU7jjYhRQMYTe-MOOEdo0bn2PP15_F3x477DA27oEKtHqSD_bqxbOSoIJrZjt3dfOOogwTPpuz7dIJ7ewNXpyeXn8_4MEmBu0wXM26ssL6pCetPeeelqI32qglk73gTGu09yqLHRa7Gpy8ai26STpssZLlHtb4Fq-2kDTvA0JwpVHCNSI3PtSnqMtQl3gQW2ayVyRMQczJWboAZp2kXt9USIJlIXyHpq0j6SiZwsHhn2oNsPLt6b86dahC4rloejwQ-LH5GUaH8h23D5J7WSI1-N7q0CWz3XF18LpNaSK2zBA7nbF7--f_3svv8Xt7CmqQamFjlvQers5_34R0aMbP6fTypfwGef-mP priority: 102 providerName: ProQuest |
Title | NEAT1 Decreasing Suppresses Parkinson’s Disease Progression via Acting as miR-1301-3p Sponge |
URI | https://link.springer.com/article/10.1007/s12031-020-01660-2 https://www.ncbi.nlm.nih.gov/pubmed/32712773 https://www.proquest.com/docview/2476372239 https://www.proquest.com/docview/2427523840 |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB5Be-GCCuUntKyMhLiApdiJ7fiYpbtUIFZV6UrLhciJHakSza6abaXe-hq8Hk_C2El2hQpInHyI40QznplvPD8GeK1EKbmqU5rwWKCDkhlqasaoc6gmU1llVWix8Xkmj-fpx4VY9EVh7ZDtPoQkg6beFrtx3IDUuzsIU2RMUfHuCu-74y6e83zjZrE0nOrFmRY0k1r2pTJ_XuN3c3QHY96JjwazM92Dhz1eJHnH4EdwzzWPYT9v0Fe-uCFvSMjgDEfj-_BtNsnPGDkKSNCfARB_Z2foDt4SX94cKr1-3v5oyVEXlyEnPj2ra81Brs8NySufBk1MSy7OTylaHkaTFfmyWuK_PYH5dHL2_pj29yfQKlFiTbVhxtal7_AnbWU5K7WysnYe5VjtamUtSqDFSVWJoxW1QedIxXXiktSiMX8KO82ycc-BIIgR0lU1i7VNlRZl5soM5d8gc5XUaQRsIGNR9c3F_R0X34ttW2RP-gJJXwTSFzyCt5t3Vl1rjX_OPhy4U_Ri1hY8RfWoEOHoCF5tHqOA-KiHadzyys_hCr1tdGQjeNZxdfO5hCvGlUoieDewebv43__lxf9NP4AH3GfChFzvQ9hZX165lwhl1uUI7quFGsFuPh2PZ3788PXTBMfxZHZyOgr7-hfLQOvX |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB5V2wNcUEv5CS1gJOACFrHj2PEBoYXdakvbVVW2Uk-EJHakSm1222xBvfEavAQPxZMwdpJdoYreesphnY01nr9vPD8AL1WcS65KQSMexghQkoxmJWPUWlSTQhZJ4Vts7I_l6Eh8Po6PV-B3Vwvj0io7negVtZkWLkb-jguUBIXGTH-YnVM3NcrdrnYjNBq22LVXPxCy1e93Bni-rzjfHk4-jWg7VYAWkYrnVGcsM2Xu-t5JUxjOcq2MLK2z_UbbUhmDfGlwUZHj08RlhpBBhWVkI2F8owNU-asiQijTg9WPw_HB4QLiMeEjimGiY5pILdsynaZYj6MAUQfX0M2SIeX_msJr_u21u1lv8rbX4F7rq5J-w1zrsGKr-7DRrxCnn12R18Rnj_qw_AZ8HQ_7E0YG3gt18Qfi5oX6zuQ1caXVvsrsz89fNRk0d0LkwKWGNW1ByPeTjPQLl4JNspqcnRxStHqMRjPyZTbFvT2Ao1uh8kPoVdPKPgaCDlQsbVGyUBuhdJwnNk9Q92TIWEpqEQDryJgWbWNzN1_jNF22ZHakT5H0qSd9ygN4s3hn1rT1uHH1Vnc6aSvidbpkyABeLH5G4XQ3Llllp5duDVeI9BFEB_CoOdXF5yKuGFcqCuBtd8zLP___Xp7cvJfncGc02d9L93bGu5twl7sMHJ9jvgW9-cWlfYou1Dx_1vItgW-3LSp_AaQtKXc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3batRA9FAqiC9SrZfYVkdQX3RoZpLMZB5EFrdLa3Up2sI-GZO5QKHNbs3W0jd_w1_xc_wSz0ySXaTYtz7lYSeb4dzvB-CFzCrBpUtpwuMMHZS8pKVjjFqLYjIVOtdhxMansdg9Sj9MsskK_O57YXxZZS8Tg6A2U-1j5Ns8RU6QqMzUtuvKIg6Go3ezM-o3SPlMa79OoyWRfXt5ge5b83ZviLh-yflo5_D9Lu02DFCdyGxOVclK4yo_A08YbTirlDTCWW8HGGWdNAZp1OAhXeHTZK5E90HGLrFJasLQAxT_t2SSMc9jcrJ09lgaYotxrjKaCyW6hp22bY8jK1HvuKHBJWLK_1WKVyzdK1naoPxGa3C3s1rJoCWze7Bi6_uwPqjRYz-9JK9IqCMNAfp1-DreGRwyMgz2qI9EEL85NMwob4hvsg79Zn9-_mrIsM0OkQNfJNYOCCE_jksy0L4Ym5QNOT3-TFH_MZrMyJfZFO_2AI5uBMYPYbWe1vYxEDSlMmG1Y7EyqVRZldsqRylUIolJodIIWA_GQncjzv2mjZNiOZzZg75A0BcB9AWP4PXinVk74OPa05s9doqO2ZtiSZoRPF_8jGzqcy9lbafn_gyX6POjOx3Boxari88lXDIuZRLBmx7Nyz___12eXH-XZ3AbGaT4uDfe34A73JfihGLzTVidfz-3W2hLzaungWgJfLtpLvkLdQYsRw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NEAT1+Decreasing+Suppresses+Parkinson%E2%80%99s+Disease+Progression+via+Acting+as+miR-1301-3p+Sponge&rft.jtitle=Journal+of+molecular+neuroscience&rft.au=Sun%2C+Qiang&rft.au=Zhang%2C+Yueliang&rft.au=Wang%2C+Songlin&rft.au=Yang%2C+Fang&rft.date=2021-02-01&rft.pub=Springer+US&rft.issn=0895-8696&rft.eissn=1559-1166&rft.volume=71&rft.issue=2&rft.spage=369&rft.epage=378&rft_id=info:doi/10.1007%2Fs12031-020-01660-2&rft.externalDocID=10_1007_s12031_020_01660_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-8696&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-8696&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-8696&client=summon |